<DOC>
	<DOC>NCT02206711</DOC>
	<brief_summary>The purpose of this study is to assess the pharmacokinetics (PK), metabolism, routes and extent of elimination, safety and tolerability of a single oral dose of [14C] BMS-955176 in healthy male subjects. There is no formal research hypothesis to be statistically tested for this study.</brief_summary>
	<brief_title>Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.</brief_title>
	<detailed_description />
	<criteria>Healthy Male subjects Ages 1850 years Body weight of at least 110 lbs (50kg) BMI of 18 to 32 kg/m^2 nonsmoking Clinically significant diagnostic or therapeutic radiation exposure within the previous 12 months (eg serial Xray or CAT scans, barium meals). gastrointestinal disease including gastrointestinal surgery constipation or irregular bowel movements</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>